PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Scientific Reports0 citationsOpen Access

Intravenous transplantation of multi-lineage differentiating stress enduring cell promotes functional recovery after traumatic brain injury in mice

View Full Paper
KSKeitaro ShiraishiSYShusuke YamamotoYKYoshihiro Kushida

Key Points

  • To evaluate the effects of intravenous Muse cell transplantation on recovery after traumatic brain injury in a mouse model.
  • Created TBI model using copper cylinder on mice.
  • Administered various cell doses including Muse cells and MSCs via tail vein.
  • Assessed motor function using rotarod and cylinder tests for 84 days.
  • Conducted histological analysis for cell engraftment and fate.
  • Muse group showed significant functional recovery on rotarod and cylinder tests at 28 and 42 days post-TBI.
  • Limited recovery observed in low-dose MSCs and vehicle group.
  • High-dose MSCs had minor effects on cylinder test at 84 days.
  • Muse cells demonstrated high migration to injury area and specific neuronal markers.

Abstract

Multilineage-differentiating stress-enduring (Muse) cells are a unique subset of endogenous stem cells that are non-tumorigenic and possess pluripotent-like traits with macrophage-like functions. These cells are naturally present in bone marrow, peripheral blood, connective tissues of various organs, and the umbilical cord. Muse cells are defined by their expression of stage-specific embryonic antigen-3 (SSEA-3) and their high tolerance to cellular stress such as ischemia, oxidative injury, and inflammation. This study aimed to explore the therapeutic effects of intravenous administration of Muse cells on functional recovery after traumatic brain injury (TBI). Mouse TBI model was produced by applying a 3.5-mm-diameter copper cylinder cooled with liquid nitrogen to the right parietal bone. At 7 days after TBI, the animals randomly received an injection of either 6.0×104 human Muse cells (Muse group), 6.0×104 human mesenchymal stromal cells (low-dose MSC group), 1.6×106 human MSCs (high-dose MSC group), or PBS (vehicle group) through the tail vein (n=10 in each group). Motor function was assessed using a rotarod and cylinder test for 84 days after TBI. Subsequently, histological analysis was performed to explore the engraftment and phenotypic fate of Muse cells in the brain. Functional recovery was significantly enhanced on both rotarod and cylinder tests at 28 days and 42 days after TBI in Muse group, respectively, but not in vehicle group and low-dose MSCs group. Only limited effect was observed on cylinder test at 84 days after TBI in high-dose MSCs. Human mitochondria-positive cells were densely engrafted in the peri-TBI area in Muse group, but their number was very few in low- and high-dose MSC groups. About 60% and 20% of Muse cells were positive for NeuN and GSTpi, respectively. The findings strongly suggest that intravenously administered Muse cells aggressively migrate towards the injured brain, express specific markers for neurons and oligodendrocytes, and enhance the recovery of motor function in mice TBI model.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shiraishi et al. (2026) studied this question.

synapsesocial.com/papers/6996712d80e1323b05ec0355https://doi.org/10.1038/s41598-026-39760-5
Ask AI
Helpful
Bookmark
Share
View Full Paper